Dogwood Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.52	14.85	3.32	7.03	14.01
Cash & Short-Term Investments	6.52	14.85	3.32	7.03	14.01
Cash Growth	-56.06%	347.64%	-52.82%	-49.81%	-52.99%
Other Current Assets	1.91	1.7	0.85	1.34	1.77
Total Current Assets	8.43	16.54	4.17	8.37	15.78
Net Property, Plant & Equipment	0.18	0.22	-	-	-
Other Intangible Assets	68.99	65.71	-	-	-
Goodwill	12.4	11.81	-	-	-
Other Long-Term Assets	0.18	0.02	-	-	-
Total Assets	90.17	94.31	4.17	8.37	15.78
Accounts Payable	0.76	1.23	0.11	0.57	0.35
Accrued Expenses	2.24	1.89	0.25	0.47	0.92
Current Portion of Leases	0.06	0.05	-	-	-
Total Current Liabilities	3.06	3.18	0.36	1.04	1.28
Long-Term Debt	-	15.38	-	-	-
Long-Term Leases	0.11	0.15	-	-	-
Other Long-Term Liabilities	12.11	11.31	-	-	-
Total Long-Term Liabilities	12.22	26.85	-	-	-
Total Liabilities	15.27	30.03	0.36	1.04	1.28
Common Stock	0	0	0	0	0
Treasury Stock	-0.3	-0.3	-0.3	-	-
Additional Paid-in Capital	183.86	67.86	65.58	63.5	58.43
Accumulated Other Comprehensive Income	-0.59	-3.86	-	-	-
Retained Earnings	-108.08	-73.82	-61.47	-56.17	-43.93
Total Common Shareholders' Equity	74.9	-10.12	4.11	7.33	14.5
Minority Interest	-	74.41	-	-	-
Shareholders' Equity	74.9	64.28	4.11	7.33	14.5
Total Liabilities & Equity	90.17	94.31	4.17	8.37	15.78
Total Debt	0.16	15.59	0	0	0
Net Cash (Debt)	6.36	-0.74	3.32	7.03	14.01
Net Cash Growth	-	-	-52.82%	-49.81%	-52.99%
Net Cash Per Share	1.28	-0.72	4.42	15.88	42.05
Book Value	74.9	-10.12	4.11	7.33	14.5
Book Value Per Share	15.05	-9.85	5.47	16.55	43.52
Tangible Book Value	-6.49	-87.65	4.11	7.33	14.5
Tangible Book Value Per Share	-1.30	-85.28	5.47	16.55	43.52

Updated Mar 18, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q